- Advertisement -

Biotechnology Market Size is Expected to Exhibit USD 795.7 billion by 2026 – Global Banking And Finance Review

Market Study Report adds Global Biotechnology market report that gives meticulous investigation of current scenario of the market size, share, demand, growth, trends, companies...

Sclerostin may protect against heart disease in patients with type 2 diabetes

A study carried out by the MP20-Biomarkers of Metabolic and Bone Diseases research group at the Biohealth Research Institute in Granada (ibs.GRANADA), led by...

“Super-probiotic” bacteria created through ribosomal engineering

Using ribosome engineering (RE), researchers from Shinshu University introduced mutations affecting the protein synthesis mechanism of probiotic Lacticaseibacillus rhamnosus GG (LGG). These mutant LGGs...

Take a bath 90 minutes before bedtime to get better sleep

Researchers in the Cockrell School of Engineering found that bathing 1-2 hours before bedtime in water of about 104-109 degrees Fahrenheit can significantly improve...

US intelligence report predicts greater global role for biotechnology – Genetic...

Biotechnology could potentially account for about 20 percent of the global economy by 2040, with agricultural and manufacturing uses the main drivers and health...

Astrea Bioseparations acquires Delta Precision Ltd, a leading manufacturer of chromatography...

Astrea Bioseparations (“Astrea Bio”), a leading provider of high-quality bioseparation and purification technologies, announced today the acquisition of Delta Precision Ltd. (“Delta Precision”), a...

The Emerging Power of Mass Spectrometry in Oncology

Globally, the incidence of newly diagnosed cancer cases is projected to increase over the next decade.1 Despite advancements in personalized medicine and therapeutic options,...

Novartis Shares Slide After Neuromuscular Candidate Acquired with Avidity Fails Phase...

Novartis shares fell the most in a single day since the COVID-19 pandemic after the pharma giant acknowledged that its neuromuscular candidate delpacibart etedesiran...

The Emerging Power of Mass Spectrometry in Oncology

Globally, the incidence of newly diagnosed cancer cases is projected to increase over the next decade.1 Despite advancements in personalized medicine and therapeutic options,...

Novartis Shares Slide After Neuromuscular Candidate Acquired with Avidity Fails Phase III Trial

Novartis shares fell the most in a single day since the COVID-19 pandemic after the pharma giant acknowledged that its neuromuscular candidate delpacibart etedesiran...

NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne Gene Therapy

Switzerland-headquartered NewBiologix signed an agreement with Synastra Biotechnology to develop a stable producer cell line for Synastra’s investigational Duchenne muscular dystrophy (DMD) gene therapy...

more new items

The Emerging Power of Mass Spectrometry in Oncology

Globally, the incidence of newly diagnosed cancer cases is projected to increase over the next decade.1 Despite advancements in personalized medicine and therapeutic options,...

Novartis Shares Slide After Neuromuscular Candidate Acquired with Avidity Fails Phase...

Novartis shares fell the most in a single day since the COVID-19 pandemic after the pharma giant acknowledged that its neuromuscular candidate delpacibart etedesiran...

NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne...

Switzerland-headquartered NewBiologix signed an agreement with Synastra Biotechnology to develop a stable producer cell line for Synastra’s investigational Duchenne muscular dystrophy (DMD) gene therapy...